Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in ...
A bioadaptor implant that actively adapts to vessel physiology was linked to lower target lesion failure and target vessel ...
InterVene’s Recana, a mechanical thrombectomy catheter designed to address venous in-stent restenosis (ISR) and clear vessel obstructions, has received 510(k) clearance from the US Food and Drug ...
After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...
Most forms of income count as taxable — but not all. Here’s how to calculate yours and some ways to reduce your liability. Many, or all, of the products featured on this page are from our advertising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback